1b

General Information


DRACP ID  DRACP05400

Peptide Name   1b

Sequence  RLLRLLRLL

Sequence Length  9

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  5(6)-Carboxyfluorescein

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C54H104N18O10

Absent amino acids  ACDEFGHIKMNPQSTVWY

Common amino acids  L

Mass  130842

Pl  12.8

Basic residues  3

Acidic residues  0

Hydrophobic residues  6

Net charge  3

Boman Index  -1524

Hydrophobicity  103.33

Aliphatic Index  260

Half Life 
  Mammalian: 3.5 hour
  Yeast: 10 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25188671

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2141

DRACP is developed by Dr.Zheng's team.